Search
Search
Share
Corporate Responsibility
Dividend
Result
Employees
Sales
Divisions
Strategy
Executive Board
Home
·
|
Merck Group
·
|
Contact
·
|
Deutsch
·
|
Sitemap
·
|
Search
your search: Result
Relevance of hit 1%
back to search result index
|
New search
Index
22
23
24
25
26
27
28
29
30
31
32
33
34
Notes to the consolidated income statement
Audited
[22] Sales
[23] Royalty, license and commission income
[24] Cost of sales
[25] Marketing and selling expenses
[26] Royalty, license and commission expenses
[27] Administration expenses
[28] Other operating expenses and income
[29] Research and development costs
[30] Amortization of intangible assets
[31] Financial
result
[32] Income tax
[33] Non-controlling interest
[34] Earnings per share
search hit 52
of
76
CHART GENERATOR
Interactive chart tool
SERVICES
Recommend page
Print page
Compare to 2012
Order online
Glossary
Downloads
Transformation on track
Group Management Report
Fundamental Information about the Group
Divisions
Merck Serono
Objectives and strategies
Business strategies of the divisions
Internal management system
Group and Division KPIs
Corporate Responsibility
Employees
Research and Development
Merck Serono
Merck Serono pipeline
Merck Millipore
Report on Economic Position
Review of forecast
Course of business and economic position
Business development
Expenses
Result
Assets and liabilities
Merck Serono
Business development
Regions
Major products
Expenses
Result
Consumer Health
Business development
Regions
Result
Performance Materials
Business development
Regions
Result
Merck Millipore
Business development
Regions
Expenses
Result
Corporate and Other
Report on Risks and Opportunities
Business-related risks and opportunities
Risks and opportunities of product quality and availability
Financial risks and opportunities
Legal risks
Risks and opportunities of information technology
Report on Expected Developments
Merck Group
Merck Serono
Consumer Health
Performance Materials
Merck Millipore
Subsequent Events
Corporate Governance
Statement on Corporate Governance
Compensation report
Executive Board
Corporate Governance Practices
Values and compliance
Procedures of the corporate bodies
Board of Partners of E. Merck KG
Report of the Supervisory Board
Financial Statements
Income Statement
Notes
Accounting policies
Management judgments and sources of estimation uncertainty
Consolidation methods
Currency translation
Research and development
Financial instruments: Derivative and hedging relationships
Deferred taxes
Provisions for pensions and other post-employment benefits
Notes to the consolidated income statement
Royalty, license and commission income
Other operating expenses and income
Financial result
Income tax
Notes to the balance sheet
Current financial assets
Tax receivables
Intangible assets
Tax liabilities
Provisions for pensions and other post-employment benefits
Equity
Segment reporting
Information by division/country and region
Information on segment reporting
Notes to the consolidated cash flow statement
Net cash flows from investing activities
Other disclosures
Derivative financial instruments
Management of financial risks
Other disclosures on financial instruments
Other financial obligations
Related-party disclosures
Subsequent events
Auditor's Report
Business Development 2009-2013
made by Nexxar - your next annual report online!, Vienna - Austria
search hit 52 of 76
search hit 52 of 76
